Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research (Q34460805)

2 August 2017

1 reference

title

Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research (English)

1 reference

2 August 2017

0 references

Minter KR

1

1 reference

2 August 2017

Gladwin MT

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

American Journal of Respiratory and Critical Care Medicine

2 August 2017

published in

1 reference

2 August 2017

volume

164

1 reference

2 August 2017

issue

11

1 reference

2 August 2017

page(s)

2016-2019

1 reference

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Preventing morbidity and mortality from sickle cell disease. A public health perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Patterns of mortality in sickle cell disease in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Pulmonary function in sickle cell disease with or without acute chest syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Prevalence and reversibility of lower airway obstruction in children with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Tissue factor expression by endothelial cells in sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Acute chest syndrome of sickle cell disease: new light on an old problem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Role of Chlamydia pneumoniae in acute chest syndrome of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Rib infarcts and acute chest syndrome in sickle cell diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

The acute chest syndrome in sickle cell disease. Possible role of nitric oxide in its pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Systemic fat embolism and pulmonary hypertension in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Cardiac involvement in thalassemia intermedia: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Accelerated autoxidation and heme loss due to instability of sickle hemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Spontaneous oxygen radical generation by sickle erythrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Pathogenesis and treatment of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Sickle cell anemia as an inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2104101

10.1164/AJRCCM.164.11.2104101

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference